RESUMO
BACKGROUND: Children with atopic dermatitis (AD) are often sensitized to food and aeroallergens, but sensitization patterns have not been analysed with biologic measures of disease pathogenicity. OBJECTIVE: We sought to define allergen sensitization grouping(s) using unbiased machine learning and determine their associations with skin filaggrin (FLG) and transepidermal water loss (TEWL) (assesses skin barrier integrity), S100A8 and S100A9 expression (assesses skin inflammation) and AD severity. METHODS: We studied 400 children with AD in the Mechanisms of Progression from Atopic Dermatitis to Asthma in Children (MPAACH) cohort to identify groupings of food and aeroallergen sensitizations. MPAACH is a paediatric AD cohort, aged 1-2, recruited through hospital/community settings between 2016 and 2018. We analysed these groupings' associations with AD biomarkers: skin FLG, S100A8 and S100A9 expression, total IgE, TEWL and AD severity. RESULTS: An unbiased machine learning approach revealed five allergen clusters. The most common cluster (N = 131), SPTPEP, had sensitization to peanut, egg and/or pets. Three low prevalence clusters, which included children with allergen sensitization other than peanut, egg or pets, were combined into SPTOther . SPTNEG included children with no sensitization(s). SPTPEP children had higher median non-lesional TEWL (16.9 g/m2 /h) and IgE (90 kU/L) compared with SPTOTHER (8.8 g/m2 /h and 24 kU/L; p = .01 and p < .001) and SPTNEG (9 g/m2 /h and 26 kU/L; p = .003 and p < .001). SPTPEP children had lower median lesional (0.70) and non-lesional (1.09) FLG expression compared with SPTOTHER (lesional: 0.9; p = .047, non-lesional: 1.78; p = .01) and SPTNEG (lesional: 1.47; p < .001, non-lesional: 2.21; p < .001). There were no differences among groupings in S100A8 or S100A9 expression. CONCLUSIONS AND CLINICAL RELEVANCE: In this largely clinic-based cohort of young children with AD, allergic sensitization to peanut, egg, cat or dog was associated with more severe disease and skin barrier function but not markers of cutaneous inflammation. These data need replicating in a population-based cohort but may have important implications for understanding the interaction between AD and allergic sensitization.
Assuntos
Calgranulina A/metabolismo , Calgranulina B/metabolismo , Dermatite Atópica/imunologia , Proteínas Filagrinas/metabolismo , Pele/metabolismo , Perda Insensível de Água , Animais , Gatos , Pré-Escolar , Dermatite Atópica/metabolismo , Cães , Hipersensibilidade a Ovo/imunologia , Hipersensibilidade a Ovo/metabolismo , Hipersensibilidade a Ovo/fisiopatologia , Feminino , Humanos , Lactente , Aprendizado de Máquina , Masculino , Hipersensibilidade a Amendoim/imunologia , Hipersensibilidade a Amendoim/metabolismo , Hipersensibilidade a Amendoim/fisiopatologia , Animais de Estimação/imunologia , Pele/fisiopatologia , Testes CutâneosRESUMO
BACKGROUND: Esophagitis with eosinophilia, inflammation, and fibrosis represent a chronic condition in humans with food allergies. OBJECTIVE: In this investigation, we asked whether esophagitis with an eosinophilic component is observed in young pigs rendered allergic to hen egg white protein (HEWP). METHODS: Food allergy was induced in young pigs using two protocols. In one protocol, sensitized pigs were challenged by gavage with a single dose of HEWP. Clinical signs were monitored for 24 hours, and then, gastrointestinal (GI) tissues were collected for histological examination. The phenotype of circulating, ovalbumin (OVA)-specific T cells also was examined in HEWP challenged animals. In the second protocol, sensitized animals were fed HEWP for 28 days. Animals were then examined by endoscopy and gastrointestinal tissues collected for histological examination. RESULTS: In pigs challenged by gavage with HEWP, clinical signs were noted in 5/6 pigs including diarrhoea, emesis, and skin rash. Clinical signs were not seen in any control group. Histological analysis revealed significant levels of oesophageal eosinophilic infiltration (P < .05) in 4/6 of these animals, with two also displaying eosinophilic infiltration in the stomach. Eosinophils were not increased in ileum or colon samples. Increased numbers of circulating, OVA-specific CD4+ T cells also were observed in pigs that received HEWP by gavage. In the group of animals fed HEWP, endoscopy revealed clinical signs of esophagitis including oedema, granularity, white spots, and furrowing, while histology revealed oedema, immune cell infiltration, and basal zone hyperplasia. CONCLUSIONS AND CLINICAL RELEVANCE: Food allergy in the pig can be associated with esophagitis based on histological and endoscopic findings, including eosinophilic infiltration. The young pig may, therefore, be a useful large animal model for the study of eosinophilic esophagitis in humans.
Assuntos
Linfócitos T CD4-Positivos/imunologia , Hipersensibilidade a Ovo/patologia , Esofagite Eosinofílica/patologia , Eosinófilos/patologia , Esôfago/patologia , Ovalbumina/imunologia , Animais , Colo/imunologia , Colo/patologia , Diarreia/fisiopatologia , Modelos Animais de Doenças , Hipersensibilidade a Ovo/imunologia , Hipersensibilidade a Ovo/fisiopatologia , Proteínas do Ovo/imunologia , Endoscopia do Sistema Digestório , Esofagite Eosinofílica/imunologia , Eosinófilos/imunologia , Esôfago/imunologia , Exantema/fisiopatologia , Hipersensibilidade Alimentar/patologia , Íleo/imunologia , Íleo/patologia , Imunofenotipagem , Sus scrofa , Vômito/fisiopatologiaRESUMO
OBJECTIVE: Little is known regarding food anaphylaxis in infancy. We aimed to describe specificities of food anaphylaxis in infants (≤12 months) as compared to preschool children (1-6 years). METHODS: We conducted a retrospective study of all food anaphylaxis cases recorded by the Allergy Vigilance Network from 2002 to 2018, in preschool children focusing on infants. RESULTS: Of 1951 food anaphylaxis reactions, 61 (3%) occurred in infants and 386 (20%) in preschool children. Two infants had two anaphylaxis reactions; thus, we analyzed data among 59 infants (male: 51%; mean age: 6 months [SD: 2.9]); 31% had a history of atopic dermatitis, 11% of previous food allergy. The main food allergens were cow's milk (59%), hen's egg (20%), wheat (7%) and peanut (3%) in infants as compared with peanut (27%) and cashew (23%) in preschool children. Anaphylaxis occurred in 28/61 (46%) cases at the first cow's milk intake after breastfeeding discontinuation. Clinical manifestations were mainly mucocutaneous (79%), gastrointestinal (49%), respiratory (48%) and cardiovascular (21%); 25% of infants received adrenaline. Hives, hypotension and neurologic symptoms were more likely to be reported in infants than in preschool children (P = .02; P = .004; P = .002, respectively). Antihistamines and corticosteroids were more often prescribed in preschool children than in infants (P = .005; P = .025, respectively). CONCLUSION: Our study found that in infants presenting with their first food allergy, in a setting with a high rate of infant formula use, the most predominant trigger was cow's milk. As compared to older preschool children, hives, hypotonia and hypotension were more likely to be reported in infants. We believe that this represents a distinct food anaphylaxis phenotype that can further support developing the clinical anaphylaxis criteria in infants.
Assuntos
Distribuição por Idade , Anafilaxia/epidemiologia , Hipersensibilidade Alimentar/epidemiologia , Anacardium , Anafilaxia/etiologia , Anafilaxia/fisiopatologia , Angioedema/fisiopatologia , Pré-Escolar , Tosse/fisiopatologia , Choro , Dispneia/fisiopatologia , Hipersensibilidade a Ovo/complicações , Hipersensibilidade a Ovo/epidemiologia , Hipersensibilidade a Ovo/fisiopatologia , Feminino , Hipersensibilidade Alimentar/complicações , Hipersensibilidade Alimentar/fisiopatologia , Humanos , Hipotensão/fisiopatologia , Lactente , Edema Laríngeo/fisiopatologia , Masculino , Hipersensibilidade a Leite/complicações , Hipersensibilidade a Leite/epidemiologia , Hipersensibilidade a Leite/fisiopatologia , Hipotonia Muscular/fisiopatologia , Hipersensibilidade a Noz/complicações , Hipersensibilidade a Noz/epidemiologia , Hipersensibilidade a Noz/fisiopatologia , Hipersensibilidade a Amendoim/complicações , Hipersensibilidade a Amendoim/epidemiologia , Hipersensibilidade a Amendoim/fisiopatologia , Prurido/fisiopatologia , Agitação Psicomotora/fisiopatologia , Sons Respiratórios/fisiopatologia , Estudos Retrospectivos , Convulsões/fisiopatologia , Urticária/fisiopatologia , Vômito/fisiopatologia , Hipersensibilidade a Trigo/complicações , Hipersensibilidade a Trigo/epidemiologia , Hipersensibilidade a Trigo/fisiopatologiaRESUMO
BACKGROUND: The acquisition of food allergy (FA) to previously safely consumed basic food proteins is an unusual presentation of immunoglobulin E (IgE)-mediated allergic disease. OBJECTIVE: We sought to characterize patients who developed FA to previously tolerated foods (FA-PTF), including underlying reasons for and length of elimination diet of previously tolerated foods. METHODS: Patients (n = 30) with complaints consistent with FA to foods previously consumed safely were evaluated. Clinical history was obtained, and skin prick testing and graded oral food challenges (OFC) were performed. One fatal case of FA-PTF was reported by a physician. RESULTS: Twenty-two of 30 patients (ages 1.2-50 years) were diagnosed with FA-PTF by OFC to milk (n = 17), egg (n = 2), and peanuts (n = 3). One additional patient with FA-PTF had a fatal reaction to milk. Anaphylactic reactions were reported in 12 of these 23 FA-PT patients (52%); 8 experienced multiple episodes. Atopic dermatitis was diagnosed in 52% (12/23) of patients, 8 of 12 as severe; overall, 18 of 23 (78%) of patients had marked personal atopic background. Sixteen patients (70%) initiated an elimination diet, 12 of whom did so on advice from a health care provider, before the appearance of allergic symptoms. However, in 4 patients with FA-PTF, reactivity to the food protein emerged during uninterrupted consumption. CONCLUSION: Food allergy to previously tolerated foods primarily appears after an elimination diet in atopic patients. Anaphylactic reactions are common. Health care providers should consider these risks before recommending elimination diet of tolerated foods.
Assuntos
Anafilaxia/imunologia , Dermatite Atópica/imunologia , Dieta/efeitos adversos , Hipersensibilidade a Ovo/imunologia , Hipersensibilidade a Leite/imunologia , Hipersensibilidade a Amendoim/imunologia , Adolescente , Adulto , Anafilaxia/etiologia , Anafilaxia/fisiopatologia , Criança , Pré-Escolar , Dermatite Atópica/fisiopatologia , Hipersensibilidade a Ovo/etiologia , Hipersensibilidade a Ovo/fisiopatologia , Feminino , Humanos , Imunoglobulina E/sangue , Lactente , Masculino , Pessoa de Meia-Idade , Hipersensibilidade a Leite/etiologia , Hipersensibilidade a Leite/fisiopatologia , Hipersensibilidade a Amendoim/etiologia , Hipersensibilidade a Amendoim/fisiopatologia , Testes CutâneosRESUMO
BACKGROUND: Recent guidelines recommend early peanut introduction (EPI) beginning around 4 to 6 months of age in infants with severe eczema and/or egg allergy and around 6 months for all other infants. Caregiver preferences for such practices are unknown. OBJECTIVE: To determine levels of support for early allergenic solid food recommendations among new and expecting caregivers of infants at risk for peanut allergy. METHODS: We explored preferences for EPI and in-office allergy risk assessment (IRA) through a nationally representative survey of expecting (n = 1,000) and new caregivers of infants younger than 1 year (n = 1,000). RESULTS: Among a primarily female (99.7%), married (80.3%), and white (74.4%) sample, 29% had no or vague awareness of the new guidelines, 61% had no or minimal concern for their child developing food allergy, but 54% felt timing of food introduction has moderate to strong importance for developing food allergy. Only 31% expressed willingness for EPI before or around 6 months of age, with 40% reporting willingness to introduce peanut after 11 months of age, similar to tree nuts and seafood. However, 60% reported willingness to introduce egg before 8 months of age. A total of 51% and 56.8% were unwilling to allow IRA methods, such as skin testing and oral challenge, before 11 months of age, respectively. Odds of willingness to delay peanut introduction (odds ratio, 0.79; 95% confidence interval, 0.65-0.96) and undergo challenge (odds ratio, 0.67; 95% confidence interval, 0.54-0.82) after 6 months of age were lower among expecting caregivers. CONCLUSION: Among new and expecting caregivers, there is poor current willingness and questionable support for early allergenic solid food recommendations, including IRA before introduction. Willingness was better among expecting vs current caregivers. These trends underscore a need for broader formal implementation planning to facilitate early allergen introduction and maximize its preventive benefits.
Assuntos
Alérgenos/administração & dosagem , Arachis/imunologia , Cuidadores/psicologia , Eczema/prevenção & controle , Hipersensibilidade a Ovo/prevenção & controle , Ovos/análise , Hipersensibilidade a Amendoim/prevenção & controle , Arachis/química , Criança , Eczema/imunologia , Eczema/fisiopatologia , Hipersensibilidade a Ovo/imunologia , Hipersensibilidade a Ovo/fisiopatologia , Feminino , Humanos , Lactente , Masculino , Aceitação pelo Paciente de Cuidados de Saúde/psicologia , Hipersensibilidade a Amendoim/imunologia , Hipersensibilidade a Amendoim/fisiopatologia , Guias de Prática Clínica como Assunto , Medição de Risco , Testes Cutâneos , Fatores de TempoRESUMO
Hypersensitivity to the chicken egg is a widespread disorder mainly affecting 1-2% of children worldwide. It is the second most common food allergy in children, next to cow's milk allergy. Egg allergy is mainly caused by hypersensitivity to four allergens found in the egg white; ovomucoid, ovalbumin, ovotransferrin and lysozyme. However, some research suggests the involvement of allergens exclusively found in the egg yolk such as chicken serum albumin and YGP42, which may play a crucial role in the overall reaction. In egg allergic individuals, these allergens cause conditions such as itching, atopic dermatitis, bronchial asthma, vomiting, rhinitis, conjunctivitis, laryngeal oedema and chronic urticaria, and anaphylaxis. Currently there is no permanent cure for egg allergy. Upon positive diagnosis for egg allergy, strict dietary avoidance of eggs and products containing traces of eggs is the most effective way of avoiding future hypersensitivity reactions. However, it is difficult to fully avoid eggs since they are found in a range of processed food products. An understanding of the mechanisms of allergic reactions, egg allergens and their prevalence, egg allergy diagnosis and current treatment strategies are important for future studies. This review addresses these topics and discusses both egg white and egg yolk allergy as a whole.
Assuntos
Alérgenos/imunologia , Dessensibilização Imunológica , Hipersensibilidade a Ovo/imunologia , Proteínas do Ovo/imunologia , Imunoglobulina E/biossíntese , Alérgenos/administração & dosagem , Alérgenos/química , Animais , Linfócitos B/imunologia , Linfócitos B/patologia , Basófilos/imunologia , Basófilos/patologia , Galinhas , Criança , Dieta , Hipersensibilidade a Ovo/diagnóstico , Hipersensibilidade a Ovo/fisiopatologia , Hipersensibilidade a Ovo/terapia , Proteínas do Ovo/administração & dosagem , Proteínas do Ovo/química , Clara de Ovo/química , Gema de Ovo/química , Gema de Ovo/imunologia , Humanos , Linfócitos T/imunologia , Linfócitos T/patologiaRESUMO
BACKGROUND: Live attenuated influenza vaccine (LAIV) is an intranasal vaccine recently incorporated into the United Kingdom immunization schedule. However, it contains egg protein and, in the absence of safety data, is contraindicated in patients with egg allergy. Furthermore, North American guidelines recommend against its use in asthmatic children. OBJECTIVE: We sought to assess the safety of LAIV in children with egg allergy. METHODS: We performed a prospective, multicenter, open-label, phase IV intervention study involving 11 secondary/tertiary centers in the United Kingdom. Children with egg allergy (defined as a convincing clinical reaction to egg within the past 12 months and/or >95% likelihood of clinical egg allergy as per published criteria) were recruited. LAIV was administered under medical supervision, with observation for 1 hour and telephone follow-up 72 hours later. RESULTS: Four hundred thirty-three doses were administered to 282 children with egg allergy (median, 4.9 years; range, 2-17 years); 115 (41%) had experienced prior anaphylaxis to egg. A physician's diagnosis of asthma/recurrent wheezing was noted in 67%, and 51% were receiving regular preventer therapy. There were no systemic allergic reactions (upper 95% CI for population, 1.3%). Eight children experienced mild self-limiting symptoms, which might have been due an IgE-mediated allergic reaction. Twenty-six (9.4%; 95% CI for population, 6.2% to 13.4%) children experienced lower respiratory tract symptoms within 72 hours, including 13 with parent-reported wheeze. None of these episodes required medical intervention beyond routine treatment. CONCLUSIONS: In contrast to current recommendations, LAIV appears to be safe for use in children with egg allergy. Furthermore, the vaccine appears to be well tolerated in children with a diagnosis of asthma or recurrent wheeze.
Assuntos
Hipersensibilidade a Ovo/imunologia , Vacinas contra Influenza/administração & dosagem , Influenza Humana/prevenção & controle , Sons Respiratórios/imunologia , Vacinação , Adolescente , Criança , Pré-Escolar , Hipersensibilidade a Ovo/complicações , Hipersensibilidade a Ovo/diagnóstico , Hipersensibilidade a Ovo/fisiopatologia , Feminino , Humanos , Imunoglobulina E/sangue , Influenza Humana/complicações , Influenza Humana/imunologia , Influenza Humana/fisiopatologia , Masculino , Estudos Prospectivos , Sons Respiratórios/diagnóstico , Sons Respiratórios/fisiopatologia , Reino Unido , Vacinas AtenuadasRESUMO
BACKGROUND: The onset of eosinophilic esophagitis (EoE) after oral immunotherapy (OIT) has been repeatedly described in patients with immunoglobulin E (IgE)-mediated food allergy in recent years, but the relation between the 2 conditions has not been fully assessed and quantified. OBJECTIVE: To provide a systematic review of the evidence for an association between OIT and EoE. METHODS: Electronic searches were performed with keywords relating to EoE and OIT in the MEDLINE, EMBASE, and SCOPUS databases. Summary estimates were calculated. A fixed-effects model was used depending on heterogeneity (I(2)). Risk of publication bias was assessed by funnel plot analysis and the Egger test. RESULTS: The search yielded 118 documents, 15 of which were included in the quantitative summary. Most reported information came from children undergoing peanut, milk, and egg OIT. Significant publication bias in favor of studies reporting the development of EoE after OIT was documented. The overall prevalence of EoE after OIT was 2.7% (95% confidence interval 1.7%-4.0%, I(2) = 0%). Differences between medium-to high-quality studies and those of low quality were documented (3.5% vs 2.5%, respectively). EoE often resolved after OIT discontinuation; histologic remission of EoE achieved after allergen immunotherapy also was documented in 2 patients whose topical fluticasone treatment failed. CONCLUSION: New onset of EoE after OIT occurs in up to 2.7% of patients with IgE-mediated food allergy undergoing this treatment strategy. The limited data on the utility of allergen immunotherapy as a therapy for EoE prevent a recommendation for this treatment option.
Assuntos
Hipersensibilidade a Ovo/terapia , Esofagite Eosinofílica/etiologia , Hipersensibilidade a Leite/terapia , Modelos Estatísticos , Hipersensibilidade a Amendoim/terapia , Imunoterapia Sublingual/efeitos adversos , Adolescente , Animais , Estudos de Casos e Controles , Criança , Pré-Escolar , Hipersensibilidade a Ovo/imunologia , Hipersensibilidade a Ovo/fisiopatologia , Esofagite Eosinofílica/imunologia , Esofagite Eosinofílica/fisiopatologia , Feminino , Humanos , Masculino , Hipersensibilidade a Leite/imunologia , Hipersensibilidade a Leite/fisiopatologia , Hipersensibilidade a Amendoim/imunologia , Hipersensibilidade a Amendoim/fisiopatologia , Resultado do TratamentoRESUMO
PURPOSE: Lysozyme, obtained from egg white, is a potential food allergen used in the dairy industry to prevent late blowing of the loaf caused by the outgrowth of clostridial spores (Cl. butyricum and Cl. tyrobutyricum) during cheese aging. The aim of this study was to evaluate the possible correlation between egg protein allergy in pediatric age and sensitization to egg lysozyme, used for the preparation of Grana Padano cheese. METHODS: The tolerability of Grana Padano cheese has been evaluated in pediatric patients allergic to egg proteins through an oral provocation test with increasing amounts of cheese containing, or not, lysozyme at 12 and 24 months of aging. RESULTS: When lysozyme-sensitized children received 12-months aged and lysozyme-containing cheese, several immediate and late adverse reactions such as itching, abdominal pain, vomiting, nausea, dermatitis, rhinitis, bronchial asthma, urticaria, and angioedema were seen in 5 out of 21 subjects; only 1 out of 21 children showed an adverse reaction after challenge with 24-months-ripened lysozyme-containing cheese. CONCLUSIONS: There is a possible relationship between the severity of allergic reactions and the lysozyme-specific IgE level in blood. In particular vomiting, hypotension, and abdominal pain were present when IgE level was higher than 7 kU/L. A ripening time of 24 months may reduce allergy problems when lysozyme-containing cheese is given to sensitized subjects, probably due to the hydrolysis of antigenic epitopes during aging.
Assuntos
Antígenos/efeitos adversos , Queijo/efeitos adversos , Dieta/etnologia , Hipersensibilidade a Ovo/imunologia , Manipulação de Alimentos , Muramidase/efeitos adversos , Adolescente , Antígenos/metabolismo , Queijo/análise , Queijo/microbiologia , Criança , Pré-Escolar , Clostridium butyricum/crescimento & desenvolvimento , Clostridium tyrobutyricum/crescimento & desenvolvimento , Hipersensibilidade a Ovo/sangue , Hipersensibilidade a Ovo/dietoterapia , Hipersensibilidade a Ovo/fisiopatologia , Feminino , Fermentação , Inspeção de Alimentos , Humanos , Imunoglobulina E/análise , Itália , Masculino , Muramidase/metabolismo , Índice de Gravidade de Doença , Fatores de TempoRESUMO
BACKGROUND: The diagnostic gold standard of food allergy is the oral food challenge (OFC). Data on severe reactions and drug use during OFC are scarce. Our aims were (i) to investigate the prevalence and spectrum of reactions' severity during OFC and to assess drug use and epinephrine use in anaphylaxis due to OFC; (ii) to investigate the predictive value of the skin prick test wheal size for the outcome of OFCs. METHODS: A retrospective charts review of children undergoing OFC at three Allergy Centres between January 2007 and December 2008 was performed. RESULTS: A total of 544 OFCs were analysed. Most frequently involved foods were egg, milk and wheat. 254/526 (48.3%) were positive. 167 (65.7%) were defined mild reactions, 81 (31.9%) multiorgan reactions and 6 (2.4%) anaphylaxis. No patients had cardiovascular symptoms. Data on treatments were available in 98.8% OFCs. In half of them antihistamines were used vs. 10% cases in which steroids were preferred. Six children (2.4%) were treated with Epinephrine inhalation, 5 (2%) with beta-2 inhalation, 8 (3.1%) with steroid inhalation. One child was treated with IM Epinephrine + IV fluids. Skin prick tests predictive cut-off were 9 mm for albumen, 7 for yolk, 13 for fresh albumen, 10 for α-lactalbumin, seven for casein, eight for ß-lactoglobulin, 20 for cow's milk and 10 for fresh cow's milk. CONCLUSION: OFCs performed in controlled settings by expert Allergists are safe. Consideration needs to be given as to whether the Anaphylaxis' Guideline need to be modified when applied in treating patients undergoing OFC.
Assuntos
Anafilaxia/prevenção & controle , Hipersensibilidade a Ovo/diagnóstico , Fidelidade a Diretrizes , Hipersensibilidade a Leite/diagnóstico , Proteínas do Leite/administração & dosagem , Proteínas do Leite/efeitos adversos , Administração Oral , Animais , Bovinos , Criança , Pré-Escolar , Hipersensibilidade a Ovo/imunologia , Hipersensibilidade a Ovo/fisiopatologia , Epinefrina/administração & dosagem , Feminino , Humanos , Masculino , Hipersensibilidade a Leite/imunologia , Hipersensibilidade a Leite/fisiopatologia , Proteínas do Leite/imunologia , Valor Preditivo dos Testes , Prevalência , Sensibilidade e Especificidade , Índice de Gravidade de Doença , Testes CutâneosRESUMO
BACKGROUND: Large studies of individual thresholds and risk profiles for foods are sparse. Previous reports indicate that thresholds adjusted for the protein content in foods would be comparable. OBJECTIVE: To establish and compare clinical threshold values for egg, hazelnut, milk and peanut, and correlating them to severity of symptoms. METHODS: Seven hundred eighty-one challenges were performed in 487 patients (age range, 0.5-73.5 years). Using interval censoring survival analysis, the dose distribution of thresholds was fitted to a log-normal function. Symptom score was correlated to thresholds. RESULTS: Based on the 405 challenges resulting in objective signs, similar distribution of thresholds for hazelnut, milk, and peanut challenges were found, whereas individuals with egg allergy were bimodally distributed with a high or a low threshold. Eliciting dose in 10% (95% confidence interval) was 42.9 (24-76.8) mg whole eggs, 133.8 (95.9-186.6) mg whole hazelnut, 106.5 (59.7-190.6) mg roasted peanut, and 2.9 (1.5-5.4) mL milk. Adults showed more severe symptoms and signs than children, and peanut caused more severe reactions than the 3 other foods. CONCLUSION: Thresholds for the different foods were not comparable, and eliciting dose for the 4 foods differed, even if adjusted for protein content. Increasing age but not a low threshold dose is associated with severe symptoms on challenge. Peanuts elicit more severe reactions than the other foods.
Assuntos
Arachis/efeitos adversos , Corylus/efeitos adversos , Ovos/efeitos adversos , Hipersensibilidade Alimentar/diagnóstico , Leite/efeitos adversos , Padrões de Referência , Índice de Gravidade de Doença , Adolescente , Adulto , Idoso , Alérgenos/administração & dosagem , Alérgenos/efeitos adversos , Alérgenos/imunologia , Animais , Arachis/imunologia , Criança , Pré-Escolar , Corylus/imunologia , Relação Dose-Resposta a Droga , Hipersensibilidade a Ovo/diagnóstico , Hipersensibilidade a Ovo/imunologia , Hipersensibilidade a Ovo/fisiopatologia , Feminino , Hipersensibilidade Alimentar/imunologia , Hipersensibilidade Alimentar/fisiopatologia , Humanos , Lactente , Masculino , Pessoa de Meia-Idade , Leite/imunologia , Hipersensibilidade a Leite/diagnóstico , Hipersensibilidade a Leite/imunologia , Hipersensibilidade a Leite/fisiopatologia , Hipersensibilidade a Noz/diagnóstico , Hipersensibilidade a Noz/imunologia , Hipersensibilidade a Noz/fisiopatologia , Hipersensibilidade a Amendoim/diagnóstico , Hipersensibilidade a Amendoim/imunologia , Hipersensibilidade a Amendoim/fisiopatologia , Adulto JovemRESUMO
We report the case of a 46-year-old woman who treated her hair with a homemade egg-white based mask. After one year of weekly applications, the ingestion of egg triggered rhinitis, choking and systemic urticaria. Though the breakdown of oral tolerance to egg has been reported elsewhere in the literature, to the best of our knowledge, this is the first case of hair mask-induced allergy.
Assuntos
Asma/diagnóstico , Hipersensibilidade a Ovo/diagnóstico , Alérgenos/administração & dosagem , Alérgenos/efeitos adversos , Animais , Asma/complicações , Asma/fisiopatologia , Galinhas , Hipersensibilidade a Ovo/complicações , Hipersensibilidade a Ovo/fisiopatologia , Proteínas do Ovo/administração & dosagem , Proteínas do Ovo/efeitos adversos , Feminino , Preparações para Cabelo/efeitos adversos , Humanos , Imunoglobulina E/sangue , Pessoa de Meia-Idade , Rinite , Testes Cutâneos , Turquia , UrticáriaAssuntos
Hipersensibilidade a Ovo/imunologia , Vírus da Influenza A Subtipo H1N1/imunologia , Vacinas contra Influenza , Vacinação/métodos , Austrália/epidemiologia , Pré-Escolar , Contraindicações , Hipersensibilidade a Ovo/epidemiologia , Hipersensibilidade a Ovo/fisiopatologia , Humanos , Lactente , Vacinas contra Influenza/administração & dosagem , Influenza Humana/prevenção & controle , Monitorização Fisiológica , Guias de Prática Clínica como Assunto , Vacinação/efeitos adversosRESUMO
PURPOSE OF REVIEW: Allergy to hen's egg is common in infancy and childhood. Oral food challenges are often required to diagnose egg allergy, because of the limitation in the diagnostic accuracy of skin test and specific IgE to egg white. New molecular diagnostic technologies have been recently introduced into allergological research. In this article, we will review the recent literature regarding the potential value of these tests for the clinical management of egg-allergic patients. RECENT FINDINGS: Component-resolved diagnosis that can be combined with the microarray technology is promising as measurement of specific IgE antibodies to individual egg white components has been shown to predict different clinical patterns of egg allergy. Specific IgE to ovomucoid has been identified as a risk factor for persistent allergy and could indicate reactivity to heated egg. Ovomucoid and ovalbumin IgE and IgG4-binding epitope profiling could also help distinguish different clinical phenotypes of egg allergy. Particularly, egg-allergic patients with IgE antibodies reacting against sequential epitopes tend to have more persistent allergy. SUMMARY: Using recombinant allergens, IgE-binding epitopes, and microarrays, molecular-based technologies show promising results. However, none of these tests is ready to be used in clinical practice and oral food challenge remains the standard for the diagnosis of egg allergy.
Assuntos
Alérgenos/imunologia , Hipersensibilidade a Ovo/diagnóstico , Mapeamento de Epitopos , Análise em Microsséries , Proteínas Recombinantes/imunologia , Criança , Progressão da Doença , Hipersensibilidade a Ovo/fisiopatologia , Humanos , Imunoglobulina E/sangue , Imunoglobulina G/sangue , Ovalbumina/imunologia , Ovomucina/imunologia , Patologia Molecular/métodos , PrognósticoAssuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Hipersensibilidade a Drogas/epidemiologia , Hipersensibilidade a Drogas/terapia , Hipersensibilidade a Ovo/epidemiologia , Hipersensibilidade a Ovo/terapia , Doença de Hodgkin/epidemiologia , Doença de Hodgkin/terapia , Adolescente , Idade de Início , Alérgenos/imunologia , Angioedema , Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , Criança , Dietoterapia , Intervalo Livre de Doença , Hipersensibilidade a Drogas/diagnóstico , Hipersensibilidade a Drogas/etiologia , Hipersensibilidade a Drogas/fisiopatologia , Hipersensibilidade a Ovo/diagnóstico , Hipersensibilidade a Ovo/etiologia , Hipersensibilidade a Ovo/fisiopatologia , Ovos/efeitos adversos , Feminino , Doença de Hodgkin/complicações , Doença de Hodgkin/diagnóstico , Doença de Hodgkin/fisiopatologia , Humanos , Imunização , Ovalbumina/efeitos adversos , Ovalbumina/imunologia , Indução de Remissão , Testes CutâneosRESUMO
INTRODUCTION: Egg allergy is an adverse immune-system reaction of an IgE-mediated type, which can happen in children after egg intake and several times after their first egg intake. OBJECTIVES: Compare the results of the oral egg-challenge test in two groups of egg-sensitised children, with and without prior intake. PATIENTS AND METHODS: Retrospective study of two egg-sensitised groups (72 subjects). Group 1: 22 children without prior egg-intake. Group 2: 50 children with a clinical history of adverse reactions after egg intake. Skin prick tests, egg-white specific IgE (sIgE) and yolk specific IgE, were performed on all children. The oral egg-challenge tests were performed after a period of egg-avoidance diet and when egg-white specific IgE levels were lower than 1.5K U/L. RESULTS: 31.8% of the children in Group 1 did not tolerate egg-intake whereas 38% of the children in Group 2 did not tolerate egg-intake. Egg-avoidance periods lasted 19.5 and 18 months, respectively. Egg-white specific IgE levels went down in both groups after an egg-avoidance diet. No statistically significant differences were found between the groups and the positivity of oral egg-challenge test. CONCLUSIONS: No statistically significant differences were found in the behaviour of the two groups studied. Given the high risk of adverse reactions, it was recommended that any egg-introduction tests were to be performed in a hospital environment on the children who were sensitised to hen's egg (including children without prior egg intake).
Assuntos
Ingestão de Alimentos , Hipersensibilidade a Ovo/diagnóstico , Muramidase/imunologia , Administração Oral , Alérgenos/efeitos adversos , Criança , Pré-Escolar , Hipersensibilidade a Ovo/sangue , Hipersensibilidade a Ovo/imunologia , Hipersensibilidade a Ovo/fisiopatologia , Ovos/efeitos adversos , Feminino , Humanos , Imunização , Imunoglobulina E/sangue , Lactente , Masculino , Testes CutâneosRESUMO
BACKGROUND: Ovalbumin, ovomucoid, ovotransferrin, lysozyme, and ovomucin are known to be major allergens found in egg white. Egg white protein is composed of over 30 proteins; many of which have neither been identified nor their allergenicities characterized. This study set out to analyze whether unknown proteins that bind to IgE antibodies in serum from patients with egg allergy exist in egg white. METHODS: Diluted egg white proteins were separated by 2-dimensional (2-D) gel electrophoresis. Immunolabeling was performed on individual patient sera from 19 child patients with egg white allergy and 11 negative control subjects. Spots of egg white proteins that bound to the patients' IgE were identified by mass spectrometry-based proteomics. RESULTS: Egg white proteins were separated into 63 spots. Twenty-five of the 63 reacted with egg allergy patients' sera, and 10 of the 25 reactive spots showed IgE-reactivity to controls as well. Specific bindings to the IgE from egg allergy patients were found in 15 spots; one of which was confirmed as ovotransferrin. Among the other 14 protein spots, egg white cystatin and lipocalin-type prostaglandin D synthase (L-PGDS) were newly identified proteins that reacted with IgE in patients with egg allergy. CONCLUSIONS: We demonstrated that L-PGDS and cystatin reacted with serum IgE in patients with egg allergy. Our proteomics-based analysis in egg white gives a comprehensive map of proteins bound with IgE and should assist in enabling more accurate diagnoses and recommendations of desensitizing treatments for individual patients.